Laser assisted skin healing

Laser Assisted Skin Healing
Laser-assisted skin healing (LASH®) today allows improving postoperative comfort of patients, minimizing risks of scar complications and reducing surgical scars.
Applied with a miniaturized handheld laser device by the name of , the treatment aims to stimulate the natural mechanisms of skin regeneration and repair initiated from the stage of wound closure, i.e. from the start of the healing process.
At this stage, EkkyLite™ delivers a controlled thermal stress on the skin area to be treated that allows reducing inflammation, helping healing, strengthening resistance of the wound and reducing the risk of residual scars.
Thus, precociously directing the tissue response, this novel laser-assisted skin healing device allows preventing regeneration and tissue repair defects/flaws that cause scarring issues.
Used by European surgeons since late 2008, EkkyLite™ is commercialized by Ekkyo, a young French photomedicine company whose founder scientists and surgeons made the discovery.
Clinical validation
The LASH® treatment efficiency was/has been demonstrated through different case studies and one clinique study conducted on large horizontal abdominoplasty scars.
Conducted by Dr. Alexandre Capon, plastic surgeon at the Centre Hospitalier Universitaire de Lille, France, this clinical study had two complementary objectives: assess both safety and therapeutical and cosmetic benefits of a treatment with a 810 nm diode laser associated to a safety strip responsible of recognizing, positioning, inputting parameters and controlling the laser treatment.
Collected results confirmed the LASH® technology’s benefits: an accelerated healing process, a significant reduction of residual scars and an improvement of patients’ postoperative comfort. 12 months after laser treatment, 83% of patients showed a significant improvement of the EkkyLite™-treated section relative to the untreated one.
 
< Prev   Next >